Search results
Global Prinzmetal Angina Therapeutics Market Set for Robust Growth: Expected to Reach USD 17.2 Billi
PharmiWeb· 6 days agoThe global Prinzmetal angina therapeutics market is on an impressive growth trajectory, with forecasts indicating a market valuation surpassing USD 10.7 billion by 2023 and soaring to an anticipated ...
Brits spent 2.1billion hours watching Sky content over the past six month
The Sun· 7 days agoCentrica profits fell to £1.04billion, from £2.1billion. THE UK may miss out on new medicines because of NHS spending rules, Astrazeneca has warned. Pascal Soriot, CEO of ...
FTSE 100 gains after strong US economic data, recouping early losses
LBC· 7 days agoThe FTSE 100 finished on a high on Thursday after initially slipping to a three-month low earlier in the day. The blue-chip index rose 33 points to end the day on 8,186, a 0.4% increase. It ...
Eaton Vance Worldwide Health Sciences Fund's Strategic Moves in Q2 2024: Spotlight on ...
GuruFocus.com via Yahoo Finance UK· 7 days agoLilly and Co (NYSE:LLY), 7.54% in Novo Nordisk A/S (OCSE:NOVO B), 7% in UnitedHealth Group Inc...
AstraZeneca CEO: We're building '2 supply chains' to avoid impact of US-China tensions
Yahoo Finance· 7 days agoDespite growing tensions between the US and China, the global pharmaceutical industry continues to...
French pharma giant Sanofi ups profit forecast as Dupixent sales soar
EuroNews· 7 days agoSanofi no longer expects a fall in full-year profit after a promising set of second quarter results,...
London close: Stocks mixed on tsunami of updates, US GDP data
ShareCast· 7 days agoLondon stocks closed with mixed results on Thursday as investors processed faster-than-anticipated...
FTSE 100 Live 25 July: Wise shares halted, Revolut receives banking licence
Evening Standard· 7 days agoResults by Lloyds, Centrica and many other FTSE 100 stocks were today caught up in a wider stock...
9 Irish start-ups born out of research to keep an eye on
Silicon Republic· 7 days agoThis Research Week, we look at some of Ireland’s most promising start-ups that are backed by...
AstraZeneca, a mega-cap growth stock that just got cheaper!
Fool.co.uk via Yahoo Finance UK· 7 days agoOur writer takes a closer look at this growth stock -- which also happens to be the largest company...